<DOC>
	<DOC>NCT01447940</DOC>
	<brief_summary>Primary objective of TELEDIAB-3 study is to demonstrate that the use of Meos Telemedicine ePortal for sharing information between diabetologist and type 1 diabetic patient is not inferior to a conventional care regarding metabolic results at 12 months.</brief_summary>
	<brief_title>Prospective Assessment of Meos Telemedicine E-portal on Ambulatory Care of Type 1 Diabetic Patients</brief_title>
	<detailed_description>Meos is the name of the website (Telemedicine ePortal) tested in this trial ; it is used to share informations between diabetologist and type 1 diabetic patients.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<criteria>Patient with type 1 diabetes mellitus for â‰¥ 12 months or more Age &gt; 18 years old Patient who is followed since 6 month into investigator hospital Patient with available internet access at least once a week, and ability to understand MEOS website navigation Patient using a compatible glucose meter (One touch ultra, Optium xceed, or BG star) Patient with no easy and regular access to the Internet; Patient found to be unfit for use of the telematic tools or email tools Patient with toxicomania, alcoholism or psychological troubles Type 2 diabetic patients Patient who does not need strict metabolic objectives Pregnant or parturient women Person with no freedom (prisoner)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Telemedicine</keyword>
	<keyword>Type 1 diabetes</keyword>
	<keyword>economic cost of Type 1 diabetes</keyword>
	<keyword>ePortal Meos</keyword>
</DOC>